文献速递传染病防控与疫情报告卫生政策与健康促进

威尔士献血者SARS-CoV-2血清监测:监测系统建立及截至2022年11月的结果

Serosurveillance of SARS-CoV-2 in Welsh Blood Donors: Establishment of the surveillance system and results up to November 2022.
PubMed 文献 · Euro Surveill · 2023-01-01

威尔士利用2020年6月29日至2022年11月20日献血残留样本建立SARS-CoV-2血清监测,检测抗核衣壳(anti-N)及2021年4月12日起抗刺突(anti-S)抗体。抗-N年龄标化血清阳性率至2020年11月稳定于4.4-5.5%,2021年2月升至16.7%,2022年11月达80.2%;抗-S于2021年5月至9月由67.1%升至98.6%后维持99%以上。

要点

  • 抗-N血清阳性率2020年11月前稳定于4.4-5.5%,2021年2月升至16.7%,2022年11月达80.2%。
  • 抗-S血清阳性率2021年5月至9月由67.1%升至98.6%,此后维持99%以上。
  • 抗-N在年轻献血者及南威尔士城市地区最高;抗-S在年长献血者最高且地区间相近。

核心结论

  • 成功建立基于献血残留样本的SARS-CoV-2长期血清学监测,显示血清阳性率随年龄、民族和地点变化。

研究设计与样本

  • 利用2020年6月29日至2022年11月20日威尔士献血残留样本检测SARS-CoV-2抗-N抗体(自然感染)。
  • 2021年4月12日至2022年11月20日献血样本同时检测抗-S抗体(自然感染和疫苗接种)。

主要发现

  • 抗-N年龄标化血清阳性率至2020年11月稳定于4.4-5.5%,2021年2月升至16.7%,至2021年11月保持平稳后上升,2022年11月达80.2%。
  • 抗-S血清阳性率2021年5月至9月由67.1%升至98.6%,此后维持99%以上。
  • 抗-N血清阳性率在年轻献血者及南威尔士城市地区最高;抗-S在年长献血者最高且地区间相近。
  • 性别间无显著差异;自报黑种人、亚裔及其他少数族裔的抗-N血清阳性率高于白种人献血者,抗-S则相反。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundIn 2020, Wales experienced some of the highest rates of confirmed COVID-19 cases in Europe. We set up a serosurveillance scheme using residual samples from blood donations to inform the pandemic response in Wales.AimTo identify changes in SARS-CoV-2 antibody seroprevalence in Wales by time, demography and location.MethodsResidual samples from blood donations made in Wales between 29 June 2020 and 20 November 2022 were tested for antibodies to the nucleocapsid antigen (anti-N) of SARS-CoV-2, resulting from natural infection. Donations made between 12 April 2021 and 20 November 2022 were also tested for antibodies to the spike antigen (anti-S) occurring as a result of natural infection and vaccination.ResultsAge-standardised seroprevalence of anti-N antibodies in donors remained stable (4.4-5.5%) until November 2020 before increasing to 16.7% by February 2021. Trends remained steady until November 2021 before increasing, peaking in November 2022 (80.2%). For anti-S, seroprevalence increased from 67.1% to 98.6% between May and September 2021, then remained above 99%. Anti-N seroprevalence was highest in younger donors and in donors living in urban South Wales. In contrast, seroprevalence of anti-S was highest in older donors and was similar across regions. No significant difference was observed by sex. Seroprevalence of anti-N antibodies was higher in Black, Asian and other minority ethnicities (self-reported) compared with White donors, with the converse observed for anti-S antibodies.ConclusionWe successfully set up long-term serological surveillance of SARS-CoV-2 using residual samples from blood donations, demonstrating variation based on age, ethnicity and location.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Harker S, James SE, Murphy J, et al. Serosurveillance of SARS-CoV-2 in Welsh Blood Donors: Establishment of the surveillance system and results up to November 2022. Euro Surveill. 2023. PMID: 37166761. doi:10.2807/1560-7917.ES.2023.28.19.2200473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。